Skip to main content

Research Repository

Advanced Search

All Outputs (5)

Evaluation of tumour biomarkers associated with invasion, metastasis and immune escape in cats with exocrine pancreatic carcinoma (2025)
Journal Article
Guillén, A., Kropp, K., Rogato, F., Yale, A. D., Hetesy, G., Béguin, J., Erles, K., Priestnall, S. L., Reyes-Gomez, E., & Hardas, A. (2025). Evaluation of tumour biomarkers associated with invasion, metastasis and immune escape in cats with exocrine pancreatic carcinoma. Journal of Comparative Pathology, 220, 47-55. https://doi.org/10.1016/j.jcpa.2025.05.009

In humans and cats, pancreatic carcinoma (PC) arising from the exocrine pancreas is considered an aggressive cancer associated with a poor prognosis due to its high metastatic rate. The aim of this retrospective multi-institutional study was to inves... Read More about Evaluation of tumour biomarkers associated with invasion, metastasis and immune escape in cats with exocrine pancreatic carcinoma.

Evaluation of Decreased Kidney Function in Dogs Receiving Carboplatin: A Retrospective Cohort Study of 98 Dogs (2006–2024) (2025)
Journal Article
Yale, A., So, A., Guillen, A., Desmas-Bazelle, I., Rogato, F., & Jepson, R. (2025). Evaluation of Decreased Kidney Function in Dogs Receiving Carboplatin: A Retrospective Cohort Study of 98 Dogs (2006–2024). Veterinary and Comparative Oncology, https://doi.org/10.1111/vco.13069

Decreased kidney function is observed in some people receiving carboplatin, but limited literature explores this in dogs. The aim of this study was to evaluate the incidence and risk factors for decreased kidney function in dogs receiving carboplatin... Read More about Evaluation of Decreased Kidney Function in Dogs Receiving Carboplatin: A Retrospective Cohort Study of 98 Dogs (2006–2024).

Survival time and prognostic factors in dogs clinically diagnosed with haemangiosarcoma in UK first opinion practice (2025)
Journal Article
Taylor, C., Barry, G. J., O’Neill, D. G., Guillén, A., Price, P. P., Labadie, J., & Brodbelt, D. C. (2025). Survival time and prognostic factors in dogs clinically diagnosed with haemangiosarcoma in UK first opinion practice. PLoS ONE, 20(6), e0316066. https://doi.org/10.1371/journal.pone.0316066

Visceral haemangiosarcoma is considered clinically aggressive in dogs, with perceived
poor prognosis often leading to euthanasia at presentation. This study aimed
to determine survival times and prognostic factors in dogs with haemangiosarcoma
und... Read More about Survival time and prognostic factors in dogs clinically diagnosed with haemangiosarcoma in UK first opinion practice.

Long-term survival in a dog with suspected primary nodal plasmacytoma treated with surgical excision (2025)
Journal Article
Figueroa-González, C., Béguin, J., Garty, R., Guillén, A., & Stewart, S. (2025). Long-term survival in a dog with suspected primary nodal plasmacytoma treated with surgical excision. Vet Record Case Reports, https://doi.org/10.1002/vrc2.70072

An 8-year-old Staffordshire bull terrier presented for left submandibular lymphadenopathy. Cytology showed a monomorphic population of mature plasma cells suggestive of plasma cell neoplasia. On physical examination, no other lymphadenomegaly, cutane... Read More about Long-term survival in a dog with suspected primary nodal plasmacytoma treated with surgical excision.

Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs (2025)
Journal Article
Vigevani, N., Chalfon, C., Guillén, A., Marconato, L., Amores-Fuster, I., Tanis, J., & Finotello, R. (2025). Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs. Veterinary and Comparative Oncology, https://doi.org/10.1111/vco.13060

Histiocytic sarcoma (HS) is a highly metastatic cancer, and while response to several chemotherapy agents has been studied, the outcome remains poor. Vinorelbine (VNB) has been considered a possible treatment option, but data are limited. The aim of... Read More about Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs.